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Several studies have suggested a lack of correlation 
between sunscreen sun protection factor and protec-
tion of the skin immune system, potentially allowing 
greater damage to the skin by removing the natural 
protective erythemal response to sun exposure. De-
spite this, routine testing of immune protection af-
forded by sunscreens is not performed by industry. 
Current laboratory methods for investigating the 
efficacy of sunscreen protection of epidermal im-
mune function use the induction of contact hyper-
sensit:ivity or epidermal cell alloantigen presentation. 
Anitnal models, cell culture systems, and ilt vivo 
bUIl1an studies are commonly employed, but all these 
systelDs have significant drawbacks for use in routine 
testing. The purpose of this study was to develop an 
in vitro system for testing the immunologic protection 
afforded by sunscreens in human skin. Five test sun-
S unscreens' and sun-protective C.lothing delay the induc-tion of sunburn by fi ltering out a proportion of the ultraviolet (UV) r:ldiation reaching the epidermis. Longer times of UY exposure may be encouraged from the psychologic feeling of being protected and lack of 
painful erythema , resulting in a possible increase in UV exposure to 
wavelengths that are not filtered out. 
Sunscreen Slln protection factors (SPFs) are determined by 
erythemal protection ill lIillo and ultraviolet A and E (UV A/UYE) 
physical absorption characteristics on Diffey tape ill Il ilfO (Diffey and 
Farr, 1991). Murine studies have demonstrated that sunscreens 
provide greater erythemal protection than protection of the sys-
temic (Wolf el il[, 1993) or local cutaneous immune systems 
(Walker et ill, 1994) , causing concem that there is a lack of 
correlation between sunscreen SPF and immunologic protection. 
Studies have demonstrated conflicting results depending on 
source and protocol of irradiation and measurement of immuno-
luppression. Walker e( ill (1994) found no protection of epiderma.l 
alloantigen-presenting function with a test sunscreen fonnulation in 
mice after low-dose UV but aJso fou.nd that sunscreen efficacy was 
dependent on its vehicle and the number of times it was applied. Ho 
tI ill (1.992) demonstrated no significant protection of local immu-
nosuppression using a contact hypersensitivity model in chronically 
irradiated mice and two commercially available SPF 15 sunscreens, 
and Bestak el ill (1995) found only a low level of immunoprotection 
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screens plus a vehicle control were tested in a "blind" 
fashion for their i" vitl'o level of immune protection. 
Creams were applied in a standard manner to human 
whole skin explants and were irradiated over a range 
of physiologic doses using an Oriel solar simulator. A 
mixed epidermal lymphocyte reaction was used to 
quantify epidermal alloantigen-presenting capacity, 
in the presence or absence of test cream, for five 
explants. Results consistently demonstrated that all 
the test sunscreens protected beyond their designated 
sun protection factors, whereas the vehicle conferred 
no protection. The explant-mixed epidermal lym-
phocyte reaction system gave consistent, reproduc-
ible results and may prove useful for the allocation of 
an immune protection factor to all sunscreens. Key 
lUot'ds: ultraviolet/mixed epidel'mal lymphocyte I'eactiortlskirt 
explartt. J Invest Del'tJlatol108:859-863, 1997 
that was not related to the SPF of different sunscreens. Using 
UVE-irradiated lymphocytes, Mommas el ill (1990) demonstrated 
that creams of similar SPF (based on etl'themal protection) applied 
to quartz glass sheets at 0.1 mg per cm:! afForded different levels of 
immunologic protection. In an ill "illo human study, van Praag e/ ill 
(1991) found that after 4 wk of psora len plus UV A therapy or UW 
treat:Jnent, sunscreens did not prevent suppression of epidermal 
immune function , even though they prevented erythema. 
Many studies have demonstrated lack of full immune protection 
by sunscreens but often at UV doses that do not correlate with the 
sunscreen SPF. Wolf e/ al (1993) have shown that immunoprotec-
tion afforded by sunscreens in mice is highly dependent 0 1] UV 
dose. More recently, using appropriate UV doses and wavelengths 
similar to sunlight, Roberts and Eeasley (1995) found that the 
immune protection afforded by 10 commercial sunscreen lotions in 
mice exceeded their labeled SPFs. 
Despite a large amount of conflicting research using a variety of 
methods and suggestions tllat sunscreens mayor may not provide 
adequate immune protection up to the SPF of the cream , there is no 
routine commercial testing of iml11Ulle protection provided by 
sunscreens. Current laboratory methods for investigating the effi-
cacy of sunscreen protection of epidermal il11luune function use the 
induction of contact hypersensitivity or epidermal alloantigen pre-
sentation, but these systems have significant problems. 
Impaired induction of contact hypersensitivity following UY 
exposure ill mice has been found to be under genetic control, so 
that tolerance mayor may not emerge following low-dose UYE 
exposure depending on the genetic trait of the mouse (Noonan and 
Hoffiuan, 1994). Similar genetic polymorphism has also been 
observed in humans (Streilein e/ ill, 1994) and has been circumstan-
tially linked with a predisposition toward skin cancer. Quantifica-
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cion of epidermal alloantigen presentation in irradiated human 
volunteers requires a suction blister or punch biopsy for each 
dose/trea tment combination, would therefore not be feasible for 
large-sca le screening studies, and would be unethical for creams of 
high SPF value, which require massive exposures to UV radiation. 
T he majority of sunscreen r esearch is perfonned ill IlillO on a.nimal 
models, but the pbysiology of most animal skin is very ditferent 
from human skin , animals are expensive to maintain, and the use of 
animals in product testing is becoming socially less acceptable. 
Epidermal cell culmre system s are also used but lack the natural 
protection atfo rded by the skin 's stratum corn eum and structure, 
making sunscreen applica tion very unphysiologic. 
The development of a simple metllod for tes ting immunologic 
protection atforded by sunscreens is offundamental importance. An 
in vitro human skin system would be the most appropriate method 
of testing photo-immunoprotection a.tforded by sunscreens. 
In this study we have used a human skin explant system 
developed in our laboratory to examine the impairment of epider-
m al alJoanti.gen-pcesenting capacity with UV radiation and the 
protection atforded by several SUIlscreens. A modification of 
Sontheimer's mixed epidermal lymphocyte reaction (MELli...; 
Sontheimer, 1983) was used to assess the extent of immunosup-
pression and to test the immunologic protection atforded by five 
test sunscreens of known SPF range plus a vehicle contro\. 
MATEIUALS AND METHODS 
Characteristics of Test Sunscreens Six creams (Boots Contract Man-
uf.,cwring, Nottin gham, UK) labeled A-F were tested in a " blind" fashion 
for immunoprotective properties in an ill vilro systcm in our laboratory. 
C ream F (SPF 1.2 :t 0.1) was the polar vehicle in which aU the active 
sunscreCl1 agcnts in creams A-E were form ulated. Crcam A (SPF 5.7 :t 0.8) 
contained 2% octylmetho,.:y cinl1amate; cream B (SPF 4.5 ± 1.4) contained 
2'1., octyl dimethyl padimate-o-para aminobenzoic acid ; cream C (SPF 3.6 :t 
1.2) contained 2% phenyl benzimidazole sulfonic acid; cream D (SPF 5.0 :t 
0.9) contained 4% titanium dioxide (uncoated); and cream E (SPF 3.8 :t 
0.4) con tained 6% zinc oxide. SPF values :!: SO were dctermined by Dilley 
tape method ill "ilro. C reams A, B , and C had spectral absorptio n peaks in 
the UVB region (310-311 nm), whereas D and E contained broad-spectrum 
UV AlB sunscreens. 
UV Source and Establislunent of a M.inimal Erythema Dose E quiv-
a lent An Oriel xenon arc solar ., imulator (Oriel Corporation , Stratford, 
CT) with a spectral o utput in the UV region (UV fi lter WG320) very 
similar to natural SlInligllt (Fig 1) was u.,ed as the source of UV radiation. 
T he so lar si(nulato r was used ill Ilitro to detcrrn in c the ll1ean minilnal 
erythema dose (MED) , for slO n types II-III (n > 50). A mean MED was 
produced by a total UV dose of 4 J pef cm 2 (200 mJ UVB pec cm 2 13 .8 J 
UVA per cm 2), which was used as th e predicted MED, or MED equiva lent, 
for this assay. The I:lmp was not fi ltered for infrared or visible light, so that 
4 J UV per em2 gave 8 J totaJ energy per cm 2 . The lamp irradianec was 
monito red 13 em from the source with a hand-held wide-band thennopile 
radiometer (Medica l Physics , Dryburn H ospital, Durham, U.K.) calibrated 
against a Bentham spcctroradiometer DM150 (Bemham Instruments, Ltd, 
R.eading, U.K.) giving a UV dose rate between 14 mW per cm 2 alld 16.5 
rn W per cm 2 but consistent for the duration of each experim ent. Irradiation 
times were calculated accordingly. 
Skin Explant Preparation and Product Application Large pieces of 
fres h human slOn obtained from cosmetic breast reductions and visually 
estimated as type JJ-IlI were llsed . The underlying fat was removed and 
excess blood w;)shed o lr with phosphate buffered sa.line (PBS) (Oxoid , 
Ullipath , Hamps, U.K.) . 
Twenty-eight slOn explants of 1 X 2 cm or 1. X 3 cm were prepared from 
each piece of slOn using" template and scalpel blade and rinsed with l'BS, 
and the epidermal sur[;,ce was blotted dry with tissue. Two microliters of 
PBS or cream A- F per cm ' were app lied evenly to epidermis in a standard 
manner with a positive displacement Finnpipette (Labsystems UK, Ltd. 
Hamps, U.K.) and six strokes with a g lass rod. T he PBS o r cream was 
applied 10 min prior to irradiation. All creams and a PBS-trea ted control 
were tested on each piece of slOn at four different UV doses (including 
ul1irr1l dia rcd controls for each treatment). 
Irradiation Protocol C ream- or PBS-treated slOn samples were unj-
formly irradiated (:t 5%) w ithin the central 6 inches2 of a 1 0-inch2 field area 
in petri di shes (Palcon , Becton D ickenson , Plymollth. U.K.) on PBS-soaked 
Propax gauze (Smith & Nephew, Hull , U.K.). UV doses of3, 5, and 8 MED 
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Figure 1. The UV spectral output of the Oriel solar simubtor is 
very sUnilar to llatural sunlight, T he output was generated between 200 
and 400 11m using a double monochromator Bentham spectro-radiometer 
DM150 (Ben tham Instruments, Reading, Berks., U .K.), calibrated against a 
deuterium source, measu.red by the National Physics Laboratory (Keddiug. 
ton , Middlesex, U.K.). 
or 3, 5, and 12 MED equivalents were administered, giving 12, 20, 32, 4 
J UV per em' (0 .6, 1.0, 1.6, 2.4 J UVB per cm 2) and a maximuJll irradiatiOll 
time of 1 h. A heat control, using PBS-treated slOn covered with foil, Was 
also performed. UniITadiated explants treated with the test creams and PH 
were left uncovered on PBS-soaked gauze in a shaded area of the sallle 
room . 
Samples were incubated for 1 h directly after irradiation in RPMI 1640 
(GlUCO, BRL, Paisley, U.K.) supplemented with 500 ru penicillin per Illl 
(GIDCO), 500 J.l.g streptomycin per ml (GIDCO), and 25 J.l.g amphotericit, 
B per ml (GlUCO), in order to deconta ... ni natc the skin . 
Generation of Epidermal Cell Suspensions from Irradiated Skit, 
Explants The epidermal surface of each explant was cut into cllitt 
shaUow strips (2 X 10 111m) with fi ne curved scissors and placed into petti 
dishes (Falcon) containing PBS. Samples were rinsed and incubated over, 
night at 4°C in 2 mg dispase II ncutral protease per ml (Boehring~ 
Mannheim. MalU1heim, Germany) in PBS. 
Sal11ples were left to acclimatize to room temperature , and fi.ne curved 
forceps were then used to peel the ep ide rmis frOI11 the dermis. Epjderm<ij 
sheets were placed directly into a solution of c:llciul11 magnesium-free PB~ 
(GmCO) and 0 .05% trypsin /O.02% ethylcnediaminctetraacetic acid 
(GIDCO) and incubated in a humidified enviro nmellt for 20-35 min at 
37°C and 5% C02 /95% air. A single-cell suspe nsion was generated for eac!;, 
explant (:t treatment) by mechanical disruptio n of the trypsinizcd cpidel\. 
mis, by two to three passages through a 10-1111 s)'I"inge (Sherwood MediCal 
Ballymoney, U .K.) and filtration through gauze soaked with heat-illacti: 
vatcd newborn calf serum (GIDCO). 
Cells were washed w ith R.PMI , pe lleted (600 X g for 5 mill), and 
res uspended in assay mcci.ium (R .. PMI 1640 supplcmented with 50 I 
penicillin pcr ml (GrnCO), 50 J.l.g streptomycin pet tnl (GrnCO), 2 <m\1 
L-glutamine (GlUCO), alld 5% heat-inactivated pooled normal 11l1111<tn 
serum) . Epidermal ceUs were enumerated and viabilities assessed USLng 
acridi ne orange (Sigma-Dorset, U.K.) /ethidiulll bromide (Sigma) vi(;)'l 
stains at l.5 J.l.g per ml and 5.0 fl-g per ml, respective ly, ill PBS. Viabiliti , 
were found to be consistently greater than 85%. Cell concentrations we~ 
adjusted to 10" viabk cells per ml in assay mediml1 and used in all MELR as 
the stimulator ceU population. 
Isolation oEPeripheraJ Blood Mononuclear Cells Allogeneic periph. 
era l blood mo nonuclear cells (PBM Cs) wcre used as responder cells in tl)c 
MELR. PBMCs were separated fro m fresh heparinized (10-20 units per nl\, 
C Po Pharmace utica ls Ltd., Wrexham, U.K.) venous blood taken from two 
or three he,d thy human volun teers for each experiment and were isobt~ 
011 a Lymphoprep (Nycomed PlwTm3 AS, Oslow, Norway) gradient hI" 
centrifugation at 800 X g for 20 min :It room temperature. Cells we~ 
washed and en umerated as for epidefmal cells and thell adjusted to 3 X IQ' 
per 1111 in assay medium, giving two or three dilFercnt responder pop ulo. 
tions. 
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AssessIttent of the Functional Activity of Explant Epidermal Cells 
The alloantigen-presenting capacity of explant epidermal cells was deter-
mined with the allogeneic mixed epidenna! celllyrnphocyte reaction. PBMCs 
and epidenn:tl cells were co-cultured at a ratio of3:1 in a total volume of200 
ILl per w-eU ill 96-well round-bottom micro titer plates (Nunc, Naperville, lL). 
All three PDMC (responder) populations were used per epidermal (stimulator) 
urotmen~, and each responder/stimulator combination was pipetted ill rripLi-
carc. The plates were incubated for a total of 6 d at 37°C in a hUlnidified 
enviro0J11ent with 5% CO, /9S% air. Controls of epidermal cells alone and 
responde" cells alone were included 011 each plate. . . . . 
Proliferating cells were radiolabcled with 1 !LCi tnttated thYl11ldmc 
eH-TdR) per we ll (Amersham Life Science, Bucks, U.K.) on day 5 and 
harvested 18 h later OlltO glass fiber Filtcrmats (Wallac, Oy, T llrku, FmJand) 
with a Skatroll cell harvester. 
Filtecrnats were oven dried. and cell-associated radioactivity was mea-
!\l[ed with a 1205 Betaplate readet (Phatmacia, Upsala, Sweden), giving 
results in counts per minute. Background control values of tespondcr and 
epidermal cells alone were subtracted, and results were ~xpte.sscd as. a 
percentage of the lin irradiated control skin. Cream-treated ITradlated skin 
values ""ere expressed as a percentage of the appropriate cream-treated 
unirradiated skin control. 
Analysis of ResuJts One va lue was determined from the meall of 
uiplicatcs for each different responder-stimulator combination. D~ta wcre 
coUated for one explant irradiated with 0, 3, 5, and 12 MED cqlllva!ents, 
treaced w-ich creams A-F and PBS, plus four explant< all irradiated with 0, 
J, 5, and 8 MED equivalents UV and each treattl1ent, giving a total of.flve 
explants tested with all treatments. Two or three responder ~opulaoons 
were used whe11 possible per explant, but some produced lutle or no 
response and were excluded from amllysis. 
Collated data were statistically analyzed with Microsoft Excel software 
for five explants (11 responders) ;It 0 MED and 3 MED, five explants (10 
responders) at 5 MED, four explants (eight responders) at 8 MED, and one 
explant (three responders) at 12 MED. Paired two-sanlple t tests were 
pertorrned on PBS- and cream-treated skin at each UV ?ose .. C~nfidence 
levels w-erc set at 99%, and p < 0.01 was used for statlsttcal slgmficance. 
RESULTS 
Itnmunosuppression in the Explant System A UV-dose-
de'pendent reduction til. epidermal cell alloantigen-pr~s~nting fun~­
cion was found in MELR cultures, determined by tritiated thyml-
dine uptake by responder T cells stimulated with epidermal cells 
from explants irradiated with up to 12 MED equival ents ofUV (Fig 
2). The MELR resu lts suggest a m ean reductio~l in . ;l lJoan~gen 
presentation of17.9%:':: 5 .7 (:±:SEM) in explants IrradIated WJch J 
MED equivalents, and reductions of 47.2% :':: 5 .1, 67.2% :±: 4.0, 
and 68 .7% :±: 11.6 fo Ho wing 5, 8, and 12 MEDs of UV radiation, 
respectively. Maximum counts per minute of 30,0~0 ~~ 120,000 
were ohtained depending on skin and responder vanabllity . . 
A foil control (data not shown) demonstrated no 111odulatlon of 
epidermal antigen-presenting cell fuuction ,:"ith lamp heat alone, 
even after 12 MED equivalents (up to 60 111111). 
Skin availability governed the number of irradiation doses pos-
lible with aH treatments, with a full experiment requiring 28 
elCplants at 2 cm2 ; hence n values vary for each trradiation time, and 
larger SEMs were observed for smaller sample sizes. 
Itnmunoprotection with Test Creams A-F Creams A-F, 
including a vehicle control with no active sun screen agent, were 
tested in a "blind" fashion to validate the explant system and MELR 
as a technique for assessing sunscreen immunoprotection. Creams 
A-E containin g sunscreen agents all afforded full immunoprotec-
tion to 8 MED equivalents (1 .6 J UVB per cm2 ; 30.4 J UV A per 
CJ1l2) on estinlated skin types II-III compared to PBS control (Fig 3 
and Table I). Broad-spectJ"um UV AlB sunscreens 4% TiOz (cream 
D) and 6% ZnO (cream E) did not aftord significant protection to 
12 MEDs (2.4] UVB per cm2 ; 45.6 ] UVA per cm2 ), nor did the 
UVB sunscreen 2% Esca.lol 507 (cream 13). Altef11atively , UVB 
sunscreens oetyl methoh)' ctnnamate (cream A) and phenyl benz-
imidazol e sulfonic acid (cream C) afforded full and partial protec-
tion, respectively, at tlus dose. Cream F, the polar vehicle, con-
fe rre d no imlllunoprotection at any UV dose tested and at 12 MEDs 
compromised immune filllction further than ill tbe PBS-treated 
e).-plant. 
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Figure 2. Exposure to physiologic levels of solar simulated UV 
causes a dose-dependent reduction in epidermal aJloantige], pre-
sentation in huulan skin explants. Fresh explants witl. estimated skin 
type Il-Ill were irradiated witl1 up to 12 X 1 MED equivalcnts of UV 
(where 1 MED equivalent equals 4 J total UV pcr cm' based on ill lIi llo data 
for skin types II-Ill , of which 200 mJ pcr em' is UVB). Epident",1 cell 
suspensions were generated from explants immediately post-UV irradiation 
by enzymatic digestion and were co-cultured with th.ree different allogeneic 
PBMC POpu111tiollS in a 6-d MELR. Epide1111al cell aJloantigen presentation 
was determined by 3 H_ TdR incorporation by proliferating T cells. R esults 
are presented ilS a percentage ofunirnldintcd skin valucs, s.ho,\v\ng nlCallS for 
five explnIlts ± SEM. PBS was applied to explant. at 2 ILl per cm2 as a 
control for cream application. Regression analysis shows a significant 
correlation (r > 0.86, p < 0.01) between immunosuppression and UV dose 
(n "" 8) , up to 8 MEDs. 
Statistical Significance of Results Irradiated explant. treated 
with creams A-E showed the greatest differences (protective effect) 
from the irradiated control after 5 and 8 MED equivalents of UV 
radiation (p < 0 .01). The lower significance of the protection b y 
these creams after 3 MEDs (p < 0.05) is probably due to compar-
ison with only a 12.2- 23.6% reduction in mean MELR va lues. Data 
were only collated for n = 3 at tile highest dose (12 MED), giving 
larger standard elTors and lower statistical significance . 
Cream SPF Values T h e MELR results demonstrate that the 
creams containing sunscreen agents all protect epidermal alJoanti-
gen-presenting function beyond their designated SPF values (3.5 to 
5.7), which were pre-determined by Diffey tape technique ill vitro. 
Cream A, with an SPF of 5.7, and to a lesser e x tent cream C (SPF 
3.6) protected significantly, even at 12 MEDs (p < 0.01 and p < 
0 .05) . Cream F (SPF 1.2) conferred no protection above cOlltrol 
values. 
DlSCUSSION 
In 1990 N akamura d a/used full-thickness human skin e xplants for 
toxicity testing of sulfur mustard and established that skin morpho.l-
ogy and viability were unaffected by storage at 4°C or 36°C in 5% 
CO2 for 1 d . A human exph\11t system has been developed in our 
laboratory' for the immunologic testing of sunscreens ill. vitro using 
whole fresh breast skin obtained Ii-om plastic surgical procedures. 
The level and reproducibility ofUV radiation-induced immuno-
suppression in the skin has been fOlmd to vary greatly, depending 
011 the spectral output of the solar light source employed.2 Many 
artificia l UV sources have very different spectral outputs compared 
to natural sunlight. In th.is study we used an Oriel solar simulator, 
r Chu AC, Devereux J, MorrisJF. Walker S: Sun blocks-how we ll do 
they protect the skin immune system? J /t/lfe., t DL11Irnto/ 96:1023, 1991 (abstr) . 
2 Davenport V, Morris Jr, Chu AC: UV radiation induced imll1unosup-
pression of the skin is dependent Oll solar simulator bulb type. J fill/cst 
Demwt,o! 104:645 , 1995 (abstr). 
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Figure 3. Full protection of epidermal alloantigen presentation 
was afforded up to the ill ,,;Ivo SPF of five test creamS containing 
sunscreen agents . Creams A-E (conta ining sunscrcen agents), creams F 
(sunscreen vchicle alol1e), or PBS were appl ied to explants at 2 J.LI per em 2 
10 min prior to irradiation. The explants were irradiated w ith 3, 5, 8, or :1.2 
MED equiva lents UV (4 J per cm2 , 12J per cm 2 , 20J per crn 2 , 32J pc r cm 2 , 
48 J pcr cm 2 tota l UV). The immunologic protection afforded was 
determined in a 6-d MELR, as previously described. M ean results for 
in"diatcd cream-treated explants are represented as percentages of the 
appropriate cream-treated unirradiated explant function (0 ). R esults for 
cream-treated explants arc comp'l.Tcd to T'BS-treated controls to account for 
any effect of product appli ca tion (e) . Graphs (aJ to (eJ show means for 
explants treated with sunscreen-containing creamS A-E with ill lIi.ro SPF, of 
5.7, 4.5, 3.6, 5.0, a.nd 3.8. Graph (f) shows the SlInscreen vehicle, cream F 
(SPF 1.0). 
which has a stable spectral output very similar in the UV region to 
natural sunlight. 
In 1982, Aberer et ti l used epidennal cells enriched for Langer-
hans cells and pOlrtial1y purified T cells in an epidermal cell 
lymphocyte re<lction to quantify UV radiation-induced suppression 
of epidermal Langerhans cell alloantigen-presenting functi.on. 
Modification of the mixed-lymphocyte reaction by Sontheimer 
(1983) used mixed epidermal cells and unpurified allogeneic 
PBMCs in an MELR. Cooper et al (1985) used the MELR to 
examine UV-indu ced immunosuppression ill the epidel"/Jlal cell 
population and found that the results correlated well w ith those for 
enriched Langerhans cells and purified T cells. In order to assess an 
important aspect of immune fun ction in tbe skin, we measured 
Langerhans cell a\J oantigen-presenting function using a modifica-
tion of Sontheimer's (1983) MELR. 
In this study, we have demonstrated, lIsing the MELR, a 
consistent and reproducible UV dose-dependent reduction in epi-
der'mal immune function i.n the explant system. Levels of immu-
nosuppression were naturally less than in studies using irradiated 
cell suspensions (Aberer et ai, 1982), which lack the skin's protec-
tive stratum corneum, but were not as great as the 75%, reductions 
tound by Cooper ct al (1985) after 3 MEDs of UV radiation ;11 II;VO . 
T he latter study, however, used predominantly UVB, wh ich has 
been demonstrated to be the most immunosuppressive part of the 
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Table I. UV -Dose-Dependent Reduction in Immune 
Function of Irradiated Explants and Level of tbe 
Immunoprotection Afforded by Creams Containing 
Sunscreen. Agents (A-E) and Sunscreen Vehicle Alone 
(Cream F)" 
UV Dose (MED Equivalents" ) 
Trcat111ent 3 5 8 12 
PHS' 82 ::': 6 53 ± 5 33 ::': 4 
C ream A 104 .± 5 112 ::': 6 95 ::': 9 
C ream B j 11 ::': 4 100 ::': 6 102 ::': 6 
Cream C 105 ::': 7 109 ± 8 93 ::': 12 
Cream D 104 ::': 11 90 ::': 13 96 ::': 8 
C ream E 101 ::': 9 95 ::': 8 93 ::': 6 
Cream F 73 ::': 7 56 ± 9 4~ ::': 5 
11 (R)" 11 10 8 3 
n (Ex)'" 5 5 4 
(/ Exp lants wc re irrad iHtcd and epidermal alloantigcn-prcscllting fimcciOll deter_ 
min ed by 6-d MEU,- , as ill Fig 3. Results represcnt mcans for n (1<.) and n (Ex) :!: SEM, 
expressed as a percentage of unirradiated skin with the same trC;ltI11Cnt. White blocks 
denote signiftcant protection of cxpbnt imnll.m c function by ct'eam compared to PB 
trentment (p < 0.01) , and shadin g correlates to level ofimmul1Dsupprcssioll. 
"One M.ED equ ivalent equal, 4 J UV per em' (200 IllJ UVll per em'; 3.8 J UVA pet 
CIl1 2). 
, I'I3S. phosphate buffe red ,alinc. 
d n (R) is the total number of respond;lI1ts . 
e n (Ex) the Ilumber of diffe rent skin cx plun[s. 
solar spectrum (Elmets el ai, 1985). U sing mixed VV A and B 
irradiation on huma.n volunteers with skin types I-III, Chu el at 
demonstnlted a 40"/<, mean reduction in MELR with 3 MEDs and a 
30-35% reduction on two explants tested, wh ich are comparable to 
levels demonstrated here. 
Using explants it is possibl e to store the skin ovemight ilt 4°C 
before use, but less variation in triplicates and higher experimental 
values were obtained with fresh skin and freshly isolated PEMes. 
Similar counts per minute and responder variabi.1ity were found by 
Sonthein1er (1983), using freshly isolated 11.U11lan epidermaJ cells 
from suction blisters. Results here were expressed as a percentage 
of unirradiated control to reduce the biologic variability inherent in 
th e MELR system. The unadjusted data correl ates with the nOr-
malized data , demonstrating th e same trends for each experiment, 
but the range of data varies for different responders and skins, so 
that expressing the results as a function of ulurradiated skin reduces 
the variability obtained with co\Jated data. 
T he possible immunosuppressive effect of heat (Morhelin 1987) 
from the Oriel solar simu.lator was excl uded by using fo il-covered 
control skin . Controls for vehicle appJjcation (using PBS) and the 
immunologic effect of creams alone w ere also included because of 
our observations that both procedures had a sli ght effect on MELR 
results .3 Simi larly, Wolf el al (1993) and Bestak ef al (1.995) found 
a sligh t immunomodulatory effect of creams alone when they 
exa mined inflammatory responses ill mouse skin. 
All the creams tested in this study containing active Slll1SCreen 
agents protected well beyond thei.r designated SPF vaJues, a 
uSllal.ly applied (at 2 J.Ll per cm2 ) accordillg to industrial guideline 
(Boots Contract Manufacturing, personal communication) . UVB i 
generally regarded as the more immunosuppressive wavelength of 
UV ljght (Elmets et ai, 1.985), although exposure to extremely high 
accumulative doses of UVA have also been shown to be immuno_ 
suppressive (van Praag el ai, 1991) in patients treated with UVA. As 
a result of concern that UVB sunscreens may allow long-term 
accumulative exposure to UVA, allowing immunosuppression, 
combined broad- spectTum UV A + B sunscreens are now availabl , 
particularly ill high SPF sunscreens in which UV A filtration may be 
.1 Davenport V, Mo rris JF , C hu AC: R.ubbing of the skin indue an 
immunosuppressive effect. J IIwcsf DWl/aloJ 103 :44 7, 1994 (abstr) . 
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more important. Protection against UV A + B by creams D and E did 
no t correlate withan enhanced protection against immune suppres'-
sion compared to the pure UVB sunscreens (creams A, B, C); 
therefore it appears that UVB is responsible for the immunosup-
pressive effects we observed, and that the UVA dose (45.63 J per 
cm2 ) was too low to have a contributory effect. Organic UVB 
sunscreen 2% octyl metho,,-J' cinnamate (cream A) provided die 
highest immune protection with 12 MED equivalents UV and had 
the highest ill " itm SPF of all the creams tested . T he slightly 
compromising nature of the sunscreen vehicle may be attributable 
to its highly polar aud penetrative nature, w hich is required to 
effectively formulate both the organic and inorganic active sun-
screen agents in creams A-E. 
Several previously reported studies (Mommas ct. ai, 1990; van 
Praag e/ ai, 1991; Ho el ai, 1992; Wolf et ai, 1993; Bestak et ai, 1995) 
have suggested that sunscreens do not provide full immunoprotec-
tion, particularly those containing Padimate 0 and 2-ethylhe"-J'I-
4'-methoxycinn3mate (Ho et ai , 1992; Bestak et ai, 1995), and 
benzophenone 3 (Ho et aI, 1992; Wolf e/ ai, 1993). T he m~thod­
ologies employed in some of these studies have significant limita-
tions . The spectral output of the UV source is cri tical to the level of 
in:m1unoslippression observed, and studies using light SOlll"ces con-
taminated witl~ highly immunosuppressive UVC (Wolf et ai, 1993), 
not present in natural sunlight, or with spectral emmissions that do 
not approximate sunlight (Mommas ef aI, 1990; van Praag ef ai, 
1991) are inappropria te for making sunscreen claims. In studies 
using mouse models to examine the immunosuppressive effects of 
UV on the skin (Ho et ai , 1992; Wolf et ai , 1993; Bestak e/ ai, 1995), 
there are potential problem s. In their study, Walker et al (199 4) 
deIllonstra ted that sunscreens may need to be reapplied during 
irradiation because of movement and scratching by the animals, 
wher e as Roberts and Beasley found full protection with ten 
cornrnercially available sunscreens using double the recommended 
application. A single standard application therefore may not reflect 
the situation in human skin. T he relevance of the study by Bestak 
et al (1995) using " haired, pigmented, inbred mice" mld extrapo-
lating such results to human s exposed to sunlight has already 
recently been questioned by Wolf and Kripke (1996) . In cell 
culture system s, cells are more sensi tive to UV thml whole skin as 
they lack the protective stratum corneum. In addition , cell culture 
systems generally use quartz sheets for the application of sun-
screens, w hich does not account for the beneficial penetrative 
effects of sunscreens into tlle upper layers of the epidermis. In som e 
studies, Ilonepidermal cells such as lymphocytes are used as tm'get 
cells due to their high sensitivity to UV radiation insult (Mommas 
et aI, 1990) , which is completely unphysiologic. Even in studies 
using human skin, there are major methodologic fl aws. The study 
by van Praag ef al (1 991 ) used humml volunteers to test in1l11UnO-
protectioil afforded by sunscreens but used UVB or psoralen plus 
UV A l amps and administered UV doses unrelated to the sunscreen 
SPFs; the controls were perform ed on control groups different from 
tbose tested with sunscreen, and each group had a differen t range of 
skin types . 
The explant system we have employed clearly shows the level of 
epidermal immune protection afforded by sunscreen forn1Ulations 
over a range of UV doses ; it is easy to use, reproducible, and 
noninvasive and replaces the need for animal testing. Using this 
system it should be possible to designate sunscreens w ith an 
irrunun e protection f.lctOr. 
It i s important to stress that this system tests only one aspect of 
the epidermal immune system , i. e., the ability of epidermal Lang-
erhans cells (in a heterogeneous population) to present to alloge-
neic T cells. Examination of endogenous antigen presentation in an 
autologous system would provide a more rigorous tes t of epidernlal 
cell immune function, but obtaining blood and epideoll.is from the 
same donor has limited such studies fOl" routine sunscreen testing. 
The pl;mary problem with explants is the need to estimate skin 
type a nd use an MED equivalent predicted from ilL IIillo data for that 
range of skin types. Different ski.n types m ay respond very differ-
ently, however, to UV insult (V . Davenport, ].F. Morris, A.C. 
IMM UNOLOGIC PROTECTION BY SUNSCREENS IN VITRO 863 
C hu, unpublished data) so that by estimating skin color mId 
excluding skin data that do not show levels of 15-30% unmUllo-
suppression after 3 MEDs, the problem is nUnunized . Sin"lil31'ly, age 
of donor and previous sun exposure are unknown variables, but by 
using breast tissue we were able to reduce the likelihood of 
previous sun exposure. In addition , PBS-treated explants were 
examined for each piece of skin, so that data frOI11 explants that did 
not show the expected UV-dose-dependent reductions, for allY 
reason, were excluded. 
Although the creams tested in this study protected beyond their 
ill "itFo SPF values, Diffey and Farr (1991) demonstrated that human 
in lIillo and in IIUra SPF values may be poorly correlated and that the 
SPF obtained is highly UV wavelength specific. In the futuTe it 
would be preferable to correlate SPF values obtained il/ ll i"o with 
the same solar so urce used for assessing the i111111Ull e protection 
factor. In o rder to develop a more comprehensive approach to the 
testing of sunscreen formulations, our future work will encompass 
protection afforded at th e DNA and protein levels in the explant 
system . 
rVe wOllld like to tllallk Boots COli tract MnlllUnwtrillgfor their./illallcinl SlIppol1 mId 
pre",;"ioll aI lestIonlllllmiolls, nllli Dr. A.R. YO llllg nl SI]ol", 's PhOlobiology Ullil, 
for li se of the Oriel solar sill/llintor nlld gCllerntioll of tile spectral O"tp"t. 
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